Literature DB >> 18210898

Management of thromboprophylaxis during pregnancy among specialists in maternal-fetal medicine.

Holly L Casele1, William A Grobman.   

Abstract

OBJECTIVE: To evaluate practice patterns among maternal-fetal medicine physicians with regard to thromboprophylaxis in pregnancy. STUDY
DESIGN: A Web-based survey was conducted among members of the Society for Maternal-Fetal Medicine (SMFM). The Web address for the survey and unique participant identification codes were mailed out to all SMFM members. Participants answered questions about their perceptions of risk factors for thrombosis in pregnancy as well as their use of thromboprophylaxis for cesarean section and for extended antepartum bed rest (>72 hours).
RESULTS: A total of 157 physicians responded to the survey. Few respondents use routine thromboprophylaxis for patients at cesarean section (8%) or who are on antepartum bed rest (25%), but the majority would use prophylaxis for patients at cesarean (91%) or during antepartum bed rest (81%) if these patients were considered to be at high risk for thrombosis. There was, however, great variation in the conditions thought to be risk factors for thrombosis, the risk factors of great enough risk to warrant prophylaxis and the prophylactic regimens used.
CONCLUSION: Routine thromboprophylaxis for cesarean section or extended antepartum bed rest is uncommon. Although more common, risk-based thromboprophylaxis lacks a clear consensus as to which factors warrant this strategy and which regimen should be used.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18210898

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  1 in total

1.  Pregnancy-related deaths due to pulmonary embolism: findings from two state-based mortality reviews.

Authors:  Peter S Heyl; William M Sappenfield; Deborah Burch; Leticia E Hernandez; Victoria M Kavanaugh; Washington C Hill
Journal:  Matern Child Health J       Date:  2013-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.